Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03294018 · ClinicalTrials.gov registry record

Heart Rate Changes Following the Administration of Sugammadex

A clinical trial, sponsored by Joseph D. Tobias.

Completed
Registry status
276
Enrollment target

NCT03294018 is a clinical trial that has completed, run by Joseph D. Tobias. The registered enrollment target is 276 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03294018 has completed, sponsored by Joseph D. Tobias.

COMPLETED
Registry status
276 participants
Enrollment target

Study Summary

This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.

Interventions

  • OTHER Recording heart rate changes

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2017-09-06
Est. Completion 2019-01-10

Sponsor

Joseph D. Tobias

21 total trials

What the Registry Record Tells You About NCT03294018

The ClinicalTrials.gov registry entry for NCT03294018 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joseph D. Tobias, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Recording heart rate changes is the first listed.

NCT03294018 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03294018 about?

NCT03294018 is a clinical study titled "Heart Rate Changes Following the Administration of Sugammadex". This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.

What is the current status of trial NCT03294018?

This trial is currently completed. The enrollment target is 276 participants. The study started on 2017-09-06. Estimated completion is 2019-01-10.

What interventions are being tested in trial NCT03294018?

The interventions under investigation include: Recording heart rate changes (OTHER).

Who is sponsoring clinical trial NCT03294018?

This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.